SynthesisFrontiers in endocrinology2022

GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis.

Hongle Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.